000			02089 a2200541 4500
005			20250517041106.0
264		0	_c20160510
008			201605s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0132221 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlsamarah, Abdelaziz
245	0	0	_aUncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity. _h[electronic resource]
260			_bPloS one _c2015
300			_ae0132221 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aActivin Receptors, Type I _xantagonists & inhibitors
650	0	4	_aAdenosine Triphosphate _xmetabolism
650	0	4	_aAmino Acid Motifs
650	0	4	_aAmino Acid Substitution
650	0	4	_aBinding Sites _xdrug effects
650	0	4	_aBone Morphogenetic Protein Receptors, Type I _xantagonists & inhibitors
650	0	4	_aCrystallography, X-Ray
650	0	4	_aDrug Design
650	0	4	_aHumans
650	0	4	_aLigands
650	0	4	_aMolecular Docking Simulation
650	0	4	_aMolecular Dynamics Simulation
650	0	4	_aMolecular Structure
650	0	4	_aPoint Mutation
650	0	4	_aProtein Conformation
650	0	4	_aProtein Kinase Inhibitors _xchemistry
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aProtein Structure, Tertiary
650	0	4	_aPyrazoles _xchemistry
650	0	4	_aPyrimidines _xchemistry
650	0	4	_aQuinolines _xchemistry
650	0	4	_aReceptor, Transforming Growth Factor-beta Type I
650	0	4	_aReceptors, Transforming Growth Factor beta _xantagonists & inhibitors
650	0	4	_aSubstrate Specificity
650	0	4	_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors
700	1		_aLaCuran, Alecander E
700	1		_aOelschlaeger, Peter
700	1		_aHao, Jijun
700	1		_aLuo, Yun
773	0		_tPloS one _gvol. 10 _gno. 7 _gp. e0132221
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0132221 _zAvailable from publisher's website
999			_c25035999 _d25035999